期刊文献+

胆囊癌患者血清sVEGF-C和CEA水平变化及其与组织病理学特征的关系探讨 被引量:7

Correlation of serumvascular endothelial growth factor-C and carcinoembryonic antigen levels to prognosis in patients with gallbladder cancer
下载PDF
导出
摘要 目的研究血清血管内皮生长因子-C(sVEGF-C)和癌胚抗原(CEA)水平与胆囊癌患者临床和病理学特征的关系。方法2011年2月~2018年1月收治的93例胆囊癌患者,采用双抗体夹心酶联免疫吸附法检测血清sVEGF-C水平,采用放射免疫分析法检测血清CEA水平,分析血清sVEGF-C和CEA水平与胆囊癌患者临床和病理学特征的关系。结果不同肿瘤浸润程度(T分期)、肿瘤淋巴转移程度(N分期)、肿瘤远处转移(M分期)的胆囊癌患者血清sVEGF-C和CEA水平相差显著(P<0.05);中位随访22个月,在93例患者中死亡48例(51.6%),生存45例(48.4%);死亡组血清sVEGF-C水平为(84.9±20.7)pg/mL,显著高于生存组[(56.4±18.9)pg/mL,P<0.05],血清CEA水平为(138.7±49.6)μg/L,显著高于生存组[(76.8±27.4)μg/L,P<0.05];多因素Logistic回归分析显示,临床病理分期(OR=6.658,95%CI=1.800~24.632)及血清sVEGF-C(OR=4.005,95%CI=1.292~12.415)和CEA(OR=3.170,95%CI=1.482~6.849)水平是影响胆囊癌患者预后的独立危险因素(P<0.05)。结论胆囊癌患者血清sVEGF-C和CEA水平显著升高,可能与不良预后相关,值得积极的深入研究。 Objective The purpose of this study was to investigate the correlation of serumvascular endothelial growth factor-C(sVEGF-C)and carcinoembryonic antigen(CEA)levels to prognosis in patients with gallbladder cancer.Methods 93 patients with gallbladder cancer were included in this study between February 2011 and January 2018,and serum sVEGF-C levels were detected by double antibody-sandwich enzyme-linked immunosorbent assay,and serum CEA levels were detected by radioimmunoassay.The correlation of serum sVEGF-C and CEA levels to the prognosis of patients with gallbladder cancer was analyzed.Results Serum sVEGF-C and CEA levels were significantly different in gallbladder cancer patients with different tumor infiltration(Tstage),lymphatic metastasis(N stage),distant metastasis(M stage)and clinopathological stage(P<0.05);during 22 month follow-up period,45 survived(48.4%)and 48 died(51.6%);serum sVEGF-C level in the dead group was(84.9±20.7)pg/mL,significantly higher than[(56.4±18.9)pg/mL,P<0.05],and serum CEA level was(138.7±49.6)μg/L,significantly higher than[(76.8±27.4)μg/L,P<0.05]in the survival group;multivariate Logistic regression analysis showed that clinopathological stage(OR=6.658,95%CI=1.800-24.632),serum sVEGF-C(OR=4.005,95%CI=1.292-12.415)and CEA(OR=3.170,95%CI=1.482-6.849)were the independent risk factors affecting the prognosis of patients with gallbladder cancer(P<0.05).Conclusion Serum sVEGF-C and CEA levels increase greatly in patients with gallbladder cancer,which might impact the poor prognosis and warrants further investigation.
作者 李嘉 蒋基令 黄梦黎 黄俊海 陈怡媚 Li Jia;Jiang Jiling;Huang Mengli(Department of General Surgery,Traditional Chinese Medicine Hospital,Shenzhen 518021,Guangdong Province,China)
出处 《实用肝脏病杂志》 CAS 2020年第2期284-287,共4页 Journal of Practical Hepatology
基金 深圳市卫生和计划生育委员会科研计划项目(编号:SZFZ2017100)
关键词 胆囊癌 血管内皮生长因子-C 癌胚抗原 Gallbladder cancer Vascular endothelial growth factor-C Carcinoembryonic antigen Prognosis
  • 相关文献

参考文献4

二级参考文献34

  • 1马骖.26例原发胆囊癌临床分析[J].实用肝脏病杂志,2003,6(3):160-161. 被引量:1
  • 2Boutros C, Gary M, Baldwin K, Somasundar P. Gallbladdercancer: past, present and an uncertain future. Surg Oncol 2012; 21:e183-e191 [PMID: 23025910 DOI: 10.1016/j.suronc.2012.08.002].
  • 3Raki- M, Patrlj L, Kopljar M, Kli-ek R, Kolovrat M, Loncar B,Busic Z. Gallbladder cancer. Hepatobiliary Surg Nutr 2014; 3:221-226 [PMID: 25392833 DOI: 10.3978/j.issn.2304-3881.2014.09.03].
  • 4Manfredi S, Benhamiche AM, Isambert N, Prost P, Jouve JL,Faivre J. Trends in incidence and management of gallbladdercarcinoma: a population-based study in France. Cancer 2000; 89:757-762 [PMID: 10951337].
  • 5Zeng H, Zheng R, Guo Y, Zhang S, Zou X, Wang N, Zhang L,Tang J, Chen J, Wei K, Huang S, Wang J, Yu L, Zhao D, SongG, Chen J, Shen Y, Yang X, Gu X, Jin F, Li Q, Li Y, Ge H, ZhuF, Dong J, Guo G, Wu M, Du L, Sun X, He Y, Coleman MP,Baade P, Chen W, Yu XQ. Cancer survival in China, 2003-2005: apopulation-based study. Int J Cancer 2015; 136: 1921-1930 [PMID:25242378 DOI: 10.1002/ijc.29227].
  • 6Kayahara M, Nagakawa T, Nakagawara H, Kitagawa H,Ohta T. Prognostic factors for gallbladder cancer in Japan. AnnSurg 2008; 248: 807-814 [PMID: 18948808 DOI: 10.1097/SLA.0b013e31818a1561].
  • 7Wu XS, Shi LB, Li ML, Ding Q, Weng H, Wu WG, Cao Y, BaoRF, Shu YJ, Ding QC, Mu JS, Gu J, Dong P, Liu YB. Evaluationof two inflammation-based prognostic scores in patients withresectable gallbladder carcinoma. Ann Surg Oncol 2014; 21:449-457 [PMID: 24081806 DOI: 10.1245/s10434-013-3292-z].
  • 8Wang YF, Feng FL, Zhao XH, Ye ZX, Zeng HP, Li Z, Jiang XQ,Peng ZH. Combined detection tumor markers for diagnosis andprognosis of gallbladder cancer. World J Gastroenterol 2014; 20:4085-4092 [PMID: 24744600 DOI: 10.3748/wjg.v20.i14.4085].
  • 9Pilgrim CH, Groeschl RT, Turaga KK, Gamblin TC. Key factorsinfluencing prognosis in relation to gallbladder cancer. Dig Dis Sci2013; 58: 2455-2462 [PMID: 23695876 DOI: 10.1007/s10620-013-2713-y].
  • 10Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-relatedinflammation. Nature 2008; 454: 436-444 [PMID: 18650914 DOI:10.1038/nature07205].

共引文献102

同被引文献49

引证文献7

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部